Recently, Man et al. demonstrated that, in the presence of obesity-related metabolic diseases, PVAT eNOS may be even more important than the share of endothelial eNOS in promoting obesity-induced vascular dysfunction, which can ultimately be attributed to certain specific functions of PVAT eNOS [65]. This evidence concerns the gene NOS3 and metabolic disease.